Karran, Eric http://orcid.org/0000-0002-6782-5213
De Strooper, Bart http://orcid.org/0000-0001-5455-5819
Article History
Accepted: 6 January 2022
First Online: 17 February 2022
Competing interests
: E.K. is in an employee and stockholder of AbbVie. AbbVie has an anti-Aβ monoclonal antibody entering phase I clinical studies. B.D.S. is or has been a consultant for Eli Lilly, Biogen, Janssen Pharmaceutica, Eisai, AbbVie and other companies. B.D.S is also a scientific founder of Augustine Therapeutics and a scientific founder and stockholder of Muna Therapeutics.